14-day Premium Trial Subscription Try For FreeTry Free
NASDAQ:ALXN
Delisted

Alexion Pharmaceuticals Stock Price (Quote)

$182.50
+0 (+0%)
At Close: May 27, 2022

Range Low Price High Price Comment
30 days $182.50 $182.50 Friday, 27th May 2022 ALXN stock ended at $182.50. During the day the stock fluctuated 0% from a day low at $182.50 to a day high of $182.50.
90 days $182.50 $182.50
52 weeks $174.72 $187.45

Historical Alexion Pharmaceuticals prices

Date Open High Low Close Volume
Dec 06, 2018 $120.63 $121.15 $116.51 $121.04 1 603 678
Dec 04, 2018 $125.66 $129.36 $122.00 $122.30 1 914 189
Dec 03, 2018 $123.20 $127.13 $123.09 $125.47 1 361 675
Nov 30, 2018 $123.67 $124.16 $121.65 $123.15 1 315 121
Nov 29, 2018 $122.40 $124.94 $121.85 $123.34 973 071
Nov 28, 2018 $120.55 $122.92 $117.00 $122.84 1 607 225
Nov 27, 2018 $118.25 $121.10 $117.58 $120.93 1 154 925
Nov 26, 2018 $119.90 $120.64 $118.14 $119.00 1 448 385
Nov 23, 2018 $117.50 $120.44 $117.00 $118.10 384 728
Nov 21, 2018 $117.47 $119.79 $117.20 $118.11 812 584
Nov 20, 2018 $114.06 $119.02 $113.16 $116.82 1 464 411
Nov 19, 2018 $118.86 $118.88 $113.41 $115.06 1 029 267
Nov 16, 2018 $119.29 $120.15 $116.18 $118.62 1 321 367
Nov 15, 2018 $115.73 $119.93 $114.63 $119.68 1 160 189
Nov 14, 2018 $119.64 $120.82 $115.34 $116.11 1 093 600
Nov 13, 2018 $120.16 $122.15 $118.21 $118.52 903 499
Nov 12, 2018 $123.52 $123.54 $118.32 $118.60 1 215 687
Nov 09, 2018 $126.53 $126.59 $122.00 $123.44 1 338 468
Nov 08, 2018 $127.08 $128.42 $125.48 $127.18 884 265
Nov 07, 2018 $124.69 $127.80 $123.63 $127.18 1 216 112
Nov 06, 2018 $123.26 $125.38 $122.02 $123.22 993 252
Nov 05, 2018 $123.63 $124.02 $121.45 $123.21 1 228 675
Nov 02, 2018 $120.36 $123.18 $119.35 $122.82 1 645 604
Nov 01, 2018 $111.83 $119.91 $111.83 $119.70 1 965 232
Oct 31, 2018 $114.87 $115.06 $112.00 $112.07 2 223 563
Click to get the best stock tips daily for free!

About Alexion Pharmaceuticals

Alexion Pharmaceuticals Alexion Pharmaceuticals, Inc., a biopharmaceutical company, develops and commercializes life-transforming therapeutic products. The company offers Soliris (eculizumab), a monoclonal antibody for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a genetic blood disorder; and atypical hemolytic uremic syndrome (aHUS), a genetic disease. It provides Strensiq (asfotase alfa), a targeted enzyme replacement therapy for patients with hypophosp... ALXN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT